Literature DB >> 24477599

Validation of ICHD-3 beta diagnostic criteria for 13.7 Tolosa-Hunt syndrome: Analysis of 77 cases of painful ophthalmoplegia.

Xingwen Zhang1, Zhibing Zhou1, Timothy J Steiner2, Wei Zhang1, Ruozhuo Liu1, Zhao Dong1, Xiaolin Wang1, Rongfei Wang1, Shengyuan Yu3.   

Abstract

BACKGROUND: Three editions of International Classification of Headache Disorders (ICHD) diagnostic criteria for Tolosa-Hunt syndrome (THS) have been published in 1988, 2004 and 2013, in ICHD-3 beta, there have been considerable changes [corrected]. The validity of these new diagnostic criteria remains to be established.
METHODS: We retrospectively identified 77 patients with non-traumatic painful ophthalmoplegia (PO) admitted between 2003 and 2013. We reviewed patients' age at onset and gender, time courses between onset of pain and development of cranial nerve palsy, the cranial nerves involved, imaging findings, therapeutic efficacy of steroid treatment and recurrence of attacks.
RESULTS: THS was the most frequent type of PO (46/77). In THS patients, the third cranial nerve was most commonly involved (76.3%). The median time interval between pain and cranial nerve palsy was two days, although in five patients (10.9%) the interval ranged from 16 to 30 days. Definitely abnormal MRI findings were found in 24 patients (52.2%).
CONCLUSIONS: It is essential to rule out other causes of PO in diagnosing THS, with MRI playing a crucial role in differential diagnosis. It may be helpful to understand and master the entity of THS for researchers and clinicians to adjust the gradation and ranking of the diagnostic criteria. © International Headache Society 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  ICHD-3 beta; Painful ophthalmoplegia; Tolosa-Hunt syndrome; diagnostic criteria

Mesh:

Substances:

Year:  2014        PMID: 24477599     DOI: 10.1177/0333102413520082

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  16 in total

1.  Angiographic Findings in the Tolosa-Hunt Syndrome and Resolution after Corticosteroid Treatment.

Authors:  Krishnan Ravindran; Philip Schmalz; Nurhan Torun; Michael Ronthal; Yu-Ming Chang; Ajith J Thomas
Journal:  Neuroophthalmology       Date:  2017-09-06

Review 2.  Modulating mechanosensory afferent excitability by an atypical mGluR.

Authors:  Sonia Watson
Journal:  J Anat       Date:  2015-06-05       Impact factor: 2.610

3.  The evaluation of ICHD-3 beta diagnostic criteria for Tolosa-Hunt syndrome: a study of 22 cases of Tolosa-Hunt syndrome.

Authors:  Rui Hao; Yanjin He; Hong Zhang; Wei Zhang; Xiaorong Li; Yifeng Ke
Journal:  Neurol Sci       Date:  2015-03-04       Impact factor: 3.307

Review 4.  Tolosa-Hunt Syndrome: A Review of Diagnostic Criteria and Unresolved Issues.

Authors:  Paromita Dutta; Kamlesh Anand
Journal:  J Curr Ophthalmol       Date:  2021-07-05

5.  A Case Report on a Unique Explanation for Headache With Ophthalmoplegia: The Tolosa-Hunt Syndrome.

Authors:  Ayat Alhakeem; Moustafa M Elziny; Mansour Elmahdi
Journal:  Cureus       Date:  2022-06-19

6.  Double Down on Double Vision: An Unusual Case of Painful Diplopia.

Authors:  John Oghene; Sri Harsha Boppana; Pooja Reddy; Bryce D Beutler; Deepan Dalal
Journal:  Cureus       Date:  2021-12-30

7.  A Rare Case of Tolosa-Hunt-Like Syndrome in a Poorly Controlled Diabetes Mellitus.

Authors:  Glenmore Lasam; Sakshi Kapur
Journal:  Case Rep Med       Date:  2016-03-20

8.  An Interesting Case of Tolosa-Hunt Syndrome in a Young Male.

Authors:  Ghulam Murtaza; Nicholas Konowitz; Hannah Lu; Anadil Faqah; Aneesh Kuruvilla
Journal:  J Investig Med High Impact Case Rep       Date:  2017-01-01

9.  The case of a 29-year-old woman with headaches and diplopia.

Authors:  Shubadra Priyadarshini
Journal:  Ann Clin Transl Neurol       Date:  2021-06-20       Impact factor: 4.511

10.  Ophthalmoplegia and cranial nerve deficits in an adolescent with headache.

Authors:  Margarita M Corredor; Peter J Holmberg
Journal:  SAGE Open Med Case Rep       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.